BioNTech

Pfizer, BioNTech, Moderna to apply for emergency use authorization for COVID-19 vaccine

Secretary of Health and Human Services Alex Azar said Pfizer and BioNTech will be requesting Emergency Use Authorization from the Food and Drug Administration (FDA) Friday.

OAN Newsroom

Pfizer says additional analysis shows its vaccine is 95% effective in preventing COVID-19

Pfizer officials have stated additional analysis from its experimental coronavirus vaccine suggested it’s more than 95 percent effective in preventing COVID-19.